224 related articles for article (PubMed ID: 3102975)
1. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
[TBL] [Abstract][Full Text] [Related]
2. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T cell stimulation.
Tiefenthaler G; Hünig T; Dustin ML; Springer TA; Meuer SC
Eur J Immunol; 1987 Dec; 17(12):1847-50. PubMed ID: 2891540
[TBL] [Abstract][Full Text] [Related]
3. T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
Brottier P; Boumsell L; Gelin C; Bernard A
J Immunol; 1985 Sep; 135(3):1624-31. PubMed ID: 2410496
[TBL] [Abstract][Full Text] [Related]
4. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate.
Olive D; Ragueneau M; Cerdan C; Dubreuil P; Lopez M; Mawas C
Eur J Immunol; 1986 Sep; 16(9):1063-8. PubMed ID: 2428622
[TBL] [Abstract][Full Text] [Related]
6. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells.
Breitmeyer JB; Daley JF; Levine HB; Schlossman SF
J Immunol; 1987 Nov; 139(9):2899-905. PubMed ID: 2444644
[TBL] [Abstract][Full Text] [Related]
7. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
8. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
9. Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation.
Moretta A; Olive D; Poggi A; Pantaleo G; Mawas C; Moretta L
Eur J Immunol; 1986 Nov; 16(11):1427-32. PubMed ID: 2430811
[TBL] [Abstract][Full Text] [Related]
10. Rosetting of human T lymphocytes with sheep and human erythrocytes. Comparison of human and sheep ligand binding using purified E receptor.
Selvaraj P; Dustin ML; Mitnacht R; Hünig T; Springer TA; Plunkett ML
J Immunol; 1987 Oct; 139(8):2690-5. PubMed ID: 3309056
[TBL] [Abstract][Full Text] [Related]
11. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody.
Fox DA; Schlossman SF; Reinherz EL
J Immunol; 1986 Mar; 136(6):1945-50. PubMed ID: 3081635
[TBL] [Abstract][Full Text] [Related]
13. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
Selvaraj P; Plunkett ML; Dustin M; Sanders ME; Shaw S; Springer TA
Nature; 1987 Mar 26-Apr 1; 326(6111):400-3. PubMed ID: 2951597
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
[TBL] [Abstract][Full Text] [Related]
15. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
16. The ligand of the erythrocyte receptor of T lymphocytes: expression on white blood cells and possible involvement in T cell activation.
Hünig TR
J Immunol; 1986 Mar; 136(6):2103-8. PubMed ID: 2936820
[TBL] [Abstract][Full Text] [Related]
17. Triggering of the alternative pathway of human T cell activation involves members of the T 200 family of glycoproteins.
Schraven B; Roux M; Hutmacher B; Meuer SC
Eur J Immunol; 1989 Feb; 19(2):397-403. PubMed ID: 2467820
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation.
Redelman D
Cytometry; 1987 Mar; 8(2):170-83. PubMed ID: 3107949
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 monoclonal antibody.
Rouleau M; Mollereau B; Bernard A; Metivier D; Rosenthal-Allieri MA; Charpentier B; Senik A
J Immunol; 1994 May; 152(10):4861-72. PubMed ID: 7909825
[TBL] [Abstract][Full Text] [Related]
20. Studies on the monocyte dependence of T-cell proliferation induced by monoclonal antibodies directed against regions I and II of the CD2 antigen.
van Lier R; Bloemena E; Brouwer M; Van Heijst J; Weinreich S; Aarden L
Immunology; 1989 Jul; 67(3):333-8. PubMed ID: 2474490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
